Dr. Daniel Elgort currently serves as the Chief Data and Analytics Officer for M2GEN, a bioinformatics company focused on the acceleration of oncology research discoveries through superior data and analytics services. The company was formed as a spin-off of the Moffitt Cancer Center in Tampa, Florida, serving as the technological hub for an alliance of 18 NCI-designated cancer centers across the country called the ORIEN network. Prior to M2GEN, Dan was Chief Scientific Officer at Covera Health, where he built a unique healthcare data platform that collects cancer diagnosis data, and links that information to longitudinal clinical data including pharmaceutical and surgical interventions. Dan is a JHU alum, having received his bachelor's in both biomedical engineering and computer science, and he holds a Ph.D. in biomedical engineering from Case Western Reserve University.

In this episode, we discuss how bioinformatics shapes the drug development ecosystem, M2GEN’s process for moving clinical science forward, and trends in data processing and sequence technology.

Hosted by Joe Varriale.